Proactive Community Case Management (Pro-CCM) in Rural Madagascar (Pro-CCM)
Randomized Cluster Trial to Measure the Effectiveness of Home Care in Hyperendemic Rural Areas in Madagascar
The trial took place in a rural area hyper endemic for malaria, the hypothesis of which was that active detection and treatment of malaria in the population (all ages combined) in the event of a positive test could reduce the prevalence of malaria in the region. zoned. It was a two-armed, randomized, cluster-based community intervention trial:
- one arm with home treatment of malaria for the duration of the study for patients with a positive result in the rapid diagnostic test for malaria.
- a control arm with the usual malaria management procedures (ie consultation with community workers or the nearest health centers in the event of fever or suspected signs of malaria).
Before the start of monitoring, an initial survey (Baseline) was carried out in the "fokontany" (villages / cluster) included in the 2 arms, in order to determine the prevalence of malaria. Then, in the intervention arm, screening for malaria by RDT every 2 weeks in subjects with a suspected malaria case (fever or notion of fever in the 2 days preceding the visit) and treatment with Artesunate-amodiaquine (ACT) for patients with a positive RDT. At the end of the follow-up period, a final survey (Endline), based on the same questionnaires as during the Baseline, was carried out in the 2 villages of the 2 arms.
As a secondary objective, a study on anemia in women aged between 15 and 49 years was also carried out during the baseline and endline periods in order to compare the prevalence between the 2 periods
연구 개요
상세 설명
This study aims to compare the prevalence of malaria in the rural community of Mananjary after the Malaria Home Care Program (PECADOM Plus).
The study will take place in fokontany rural communes of the district of Mananjary.
This district was chosen for the following reasons:
- High prevalence of malaria in this area (31% in subjects with fever and attending medical consultation in the CSB included in the sentinel IPM fever site)
- presence of Peace Corps Volunteers (PCV) in this district. Mananjary District is situated in southeastern Madagascar, located in the central part of the Vatovavy Fitovinany Region, in the province of Fianarantsoa. It is located at 21°13'52" South and 48°20'31" East. The district is composed of one urban commune and 28 rural communes. After obtaining the agreement of the ethics committee for the realization of the study, the coordinator or the assistant coordinator of the project will make courtesy visits to all administrative and health officials in the Vatovavy Fitovinany and Mananjary District (Regional Directorate, District Chief ...).A random draw of fokontany meeting the inclusion criteria will be carried out later, to identify the distribution of fokontany in the intervention arm and control arm in the project. In addition to the 22 fokontany required, a draw of 8 reserve fokontany will be made (4 for each arm).
A courtesy visit will be conducted in the fokontany raffled. The coordinator will check the number of inhabitants in these fokontany with the information gathered at the time of the preparation of the protocol (projection of the population according to the data of INSTAT, information from the Medical Inspector of Mananjary). If the fokontany will not be eligible, the reserve fokontany will replace them in the study.
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
: Fianarantsoa, Vatovavy Fitovinany
-
Mananjary, : Fianarantsoa, Vatovavy Fitovinany, 마다가스카르, 317
- Fokontany Andranomavo
-
-
Fianarantsoa, Vatovavy Fitovinany
-
Mananjary, Fianarantsoa, Vatovavy Fitovinany, 마다가스카르, 317
- Fokontany Ambakoana
-
Mananjary, Fianarantsoa, Vatovavy Fitovinany, 마다가스카르, 317
- Fokontany Ambalamanasa
-
Mananjary, Fianarantsoa, Vatovavy Fitovinany, 마다가스카르, 317
- Fokontany Ambalaromba
-
Mananjary, Fianarantsoa, Vatovavy Fitovinany, 마다가스카르, 317
- Fokontany Ambinany Namorona
-
Mananjary, Fianarantsoa, Vatovavy Fitovinany, 마다가스카르, 317
- Fokontany Amboditandroho
-
Mananjary, Fianarantsoa, Vatovavy Fitovinany, 마다가스카르, 317
- Fokontany Ambohimiarina II
-
Mananjary, Fianarantsoa, Vatovavy Fitovinany, 마다가스카르, 317
- Fokontany Ambohinihaonana
-
Mananjary, Fianarantsoa, Vatovavy Fitovinany, 마다가스카르, 317
- Fokontany Ambolotara
-
Mananjary, Fianarantsoa, Vatovavy Fitovinany, 마다가스카르, 317
- Fokontany Andranomiteka
-
Mananjary, Fianarantsoa, Vatovavy Fitovinany, 마다가스카르, 317
- Fokontany Anilavinany
-
Mananjary, Fianarantsoa, Vatovavy Fitovinany, 마다가스카르, 317
- Fokontany Ankazotokana
-
Mananjary, Fianarantsoa, Vatovavy Fitovinany, 마다가스카르, 317
- Fokontany Anosimparihy
-
Mananjary, Fianarantsoa, Vatovavy Fitovinany, 마다가스카르, 317
- Fokontany Kianjavato
-
Mananjary, Fianarantsoa, Vatovavy Fitovinany, 마다가스카르, 317
- Fokontany Mahavoky Sud
-
Mananjary, Fianarantsoa, Vatovavy Fitovinany, 마다가스카르, 317
- Fokontany Manotro
-
Mananjary, Fianarantsoa, Vatovavy Fitovinany, 마다가스카르, 317
- Fokontany Maroamboka
-
Mananjary, Fianarantsoa, Vatovavy Fitovinany, 마다가스카르, 317
- Fokontany Sahafotahina
-
Mananjary, Fianarantsoa, Vatovavy Fitovinany, 마다가스카르, 317
- Fokontany Sandravakoka
-
Mananjary, Fianarantsoa, Vatovavy Fitovinany, 마다가스카르, 317
- Fokontany Tanambao Sud
-
Mananjary, Fianarantsoa, Vatovavy Fitovinany, 마다가스카르, 317
- Fokontany Tanambaobe
-
Mananjary, Fianarantsoa, Vatovavy Fitovinany, 마다가스카르, 317
- Fokontany Tsarahafatra
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
Inclusion criteria in community:
- Fokontany in rural communes of Mananjary district (fokontany level of safety, accessibility by the study teams, and phone network availability was assessed).
- Agreement of the chief of Fokontany for the participation of his fokontany in the study
- Fokontany with at least 1,000 inhabitants
Individual inclusion criteria:
- Resident in the relevant areas during the study period and consenting to participate
Exclusion Criteria:
Exclusion criteria in community:
- Fokontany with a total population of less than 1000 inhabitants
- Fokontany in an urban commune
- Fokontany in an area whose access is risky and perilous
- Individual exclusion criteria:
None (Non-resident present at the time of passage were tested in the study if they have suggestive signs of malaria but they were considered as visitors)
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 건강 서비스 연구
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Intervention fokontany
|
CHWs in the intervention arm conducted door-to-door fever screening for all inhabitants of all consenting households in their catchment area every fortnight.
All individuals with temperature ≥ 37.5°C or history of self-reported fever in the previous two weeks were tested with an RDT; positive individuals who were not pregnant and did not have signs of severe disease were treated with artesunate-amodiaquine according to treatment guidelines.
Individuals identified as requiring a referral during Pro-CCM visits were assisted with transfer to the healthcare center, with transportation handled by the project staff.
|
|
간섭 없음: Control fokontany
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
The primary endpoint of the study was the change in the prevalence of malaria RDT positivity in the intervention versus control fokontany.
기간: an average of 1 year
|
Difference in differences (DiD) approach comparing baseline to endline is used to compare the prevalence of malaria RDT positivity in the 2 arms
|
an average of 1 year
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
percent of households visited every two weeks
기간: The event was assessed up to 30 weeks (15 biweekly visits).
|
percent of households visited every two weeks out of the number of the households registered in initial census
|
The event was assessed up to 30 weeks (15 biweekly visits).
|
|
percent of households gave consent
기간: The event was assessed up to 30 weeks (15 biweekly visits).
|
percent of households that were visited every two weeks and gave consent for the screening during each visit
|
The event was assessed up to 30 weeks (15 biweekly visits).
|
|
Fever incidence
기간: The event was assessed up to 30 weeks (15 biweekly visits).
|
percent of fever cases out of all individuals screened during each visit
|
The event was assessed up to 30 weeks (15 biweekly visits).
|
|
Malaria incidence
기간: The event was assessed up to 30 weeks (15 biweekly visits).
|
percent of persons with positive RDT and fever cases out of all individuals screened during each visit
|
The event was assessed up to 30 weeks (15 biweekly visits).
|
|
fever cases with RDT performed
기간: The event was assessed up to 30 weeks (15 biweekly visits).
|
percent of fever cases with RDT performed
|
The event was assessed up to 30 weeks (15 biweekly visits).
|
|
RDT-positive persons treated with an ACT
기간: The event was assessed up to 30 weeks (15 biweekly visits).
|
percent of RDT-positive persons treated with an ACT during each visit
|
The event was assessed up to 30 weeks (15 biweekly visits).
|
|
The change in the prevalence of anemia in women aged between 15 and 49 years old in the intervention versus control fokontany
기간: an average of 1 year
|
Difference in differences (DiD) approach comparing baseline to endline is used to compare the prevalence of anemia in the 2 arms
|
an average of 1 year
|
공동 작업자 및 조사자
협력자
수사관
- 수석 연구원: Rila Ratovoson, MD, Institut Pasteur de Madagascar
- 연구 책임자: Milijaona Randrianarivelojosia, PhD, Institut Pasteur de Madagascar
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
IPD 공유 기간
IPD 공유 액세스 기준
IPD 공유 지원 정보 유형
- 연구_프로토콜
- ICF
- CSR
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .